18F-fluorocholine PET/CT in patients with occult biochemical recurrence of prostate cancer: Detection rate, impact on management and adequacy of impact. A prospective multicentre study.

Date publication

janvier 2018

Journal

PloS one

Auteurs

Membres identifiés du Cancéropôle Est :
Pr OLIVIER Pierre , Pr COCHET Alexandre

Tous les auteurs :
Gillebert Q, Huchet V, Rousseau C, Cochet A, Olivier P, Courbon F, Gontier E, Nataf V, Balogova S, Talbot JN,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/29425221

Résumé

To prospectively evaluate the clinical impact and the diagnostic performance of FCH-PET/CT in patients with occult biochemical recurrence of prostate cancer (PCa).

Mots clés

Aged, Aged, 80 and over, Choline, administration & dosage, Fluorine Radioisotopes, administration & dosage, Humans, Male, Middle Aged, Multimodal Imaging, Neoplasm Recurrence, Local, Positron-Emission Tomography, Prospective Studies, Prostatic Neoplasms, diagnostic imaging, Tomography, X-Ray Computed

Référence

PLoS ONE. 2018 ;13(2):e0191487